Chris Nolet

Mr. Nolet has extensive experience as a long-time audit partner and business advisor in the life sciences industry. He currently serves on the board of directors at three public life science companies, Ambrx Biopharma, Revance Therapeutics and PolarityTE. He is also a board member at a large industry association – California Life Sciences. He was on the board at Viela Bio until its acquisition in the spring of 2021, and is a former member of the Emerging Companies Section Governing Board at BIO. Chris is the former West Region Life Sciences Industry Leader and Partner at Ernst & Young (EY), having retired in June 2019 after more than 38 years in the profession. In addition to serving clients, his responsibilities included leading the West Region EY Life Sciences Industry Group and serving as a member of the Global EY Life Sciences Executive Leadership Group. Prior to joining EY, Mr. Nolet was a partner at PricewaterhouseCoopers, where he led the life sciences practice in the western U.S. He holds a B.S. in accounting from San Diego State University and is a certified public accountant in California (retired).